Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors--a review. [electronic resource]
Producer: 20041222Description: S44-9 p. digitalISSN:- 0344-5704
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.